ENTOFENTOFOTC
Loading
EBITDA Margin Over TimeStable
Percentile Rank64
3Y CAGR+214.2%
5Y CAGR-24.6%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+214.2%/yr
vs -52.8%/yr prior
5Y CAGR
-24.6%/yr
Recent acceleration
Acceleration
+267.0pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
202579.70%+236.6%
202423.68%+115.0%
2023-157.99%-6250.1%
20222.57%-99.1%
2021276.40%-15.7%
2020327.74%+104.4%
2019160.33%+210.2%
201851.68%-0.5%
201751.93%+36.9%
201637.94%-